Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 8, 2025 • 9:01 PM ET

Date/Time Source News Release
04/04/2025 04:05 PM EDT GlobeNewswire Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/01/2025 08:01 AM EDT GlobeNewswire Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
03/03/2025 07:01 AM EST GlobeNewswire Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
02/25/2025 08:00 AM EST GlobeNewswire Mersana Therapeutics to Present at Upcoming Investor Conferences
02/24/2025 04:01 PM EST GlobeNewswire Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025
02/07/2025 04:05 PM EST GlobeNewswire Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/30/2025 08:00 AM EST GlobeNewswire Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
01/10/2025 06:02 AM EST GlobeNewswire Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
01/10/2025 06:00 AM EST GlobeNewswire Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
11/13/2024 07:00 AM EST GlobeNewswire Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Page

Additional News

As of April 8, 2025 • 9:01 PM ET

Date/Time Source News Release
03/03/2025 10:13 AM EST SeekingAlpha Mersana Therapeutics, Inc. (MRSN) Q4 2024 Earnings Call Transcript
03/03/2025 08:10 AM EST Zacks Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates
03/03/2025 07:10 AM EST SeekingAlpha Mersana Therapeutics GAAP EPS of -$0.11 beats by $0.04, revenue of $16.4M beats by $8.69M
03/03/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Monday, March 3rd, 2025
03/03/2025 04:30 AM EST US Earnings Reports Expected earnings - Mersana Therapeutics Inc.
03/01/2025 02:28 PM EST SeekingAlpha Top-rated biotechs with negative enterprise values
02/28/2025 12:50 PM EST SeekingAlpha Mersana Therapeutics Q4 2024 Earnings Preview
02/26/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, February 26th, 2025
02/26/2025 04:31 AM EST US Earnings Reports Expected earnings - Mersana Therapeutics Inc.
02/06/2025 09:57 AM EST SeekingAlpha Mersana initiated at outperform at William Blair on antibody-drug conjugate potential
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.